QUAY STEVEN C (President & CEO) purchased 422.7% of their position (11.24K shares) of ATOSSA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/22/2025ACC: 0000950170-25-076523
DirectorOfficer· President & CEO
Since Jan 2019
+11.24K
Net shares
Net buyer
$9.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
11.24K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.24K
Price / share
$0.88
Trade value
$9.89K
% of position
422.7%
5/21/2025
2.66K→13.90K
Total
Net shares
+11.24K
Net value
$9.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2025 | P · Purchase | +11.24K | $0.88 | $9.89K | 422.7% | 2.66K | 13.90K |
| Total | +11.24K | $9.89K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned22.25K
Total
22.25K indirect22.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 22.25K | Indirect |
| Total | 22.25K | 22.25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported